We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+15.3%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
+$1.36B
(+15%)
Cap. Flow
+$146M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
29.42%
Holding
618
New
18
Increased
256
Reduced
279
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$169M |
| 2 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$57M |
| 3 |
Intel
INTC
|
+$24.9M |
| 4 |
Abbott
ABT
|
+$19.6M |
| 5 |
Texas Instruments
TXN
|
+$15.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$40.3M |
| 2 |
ExxonMobil
XOM
|
+$26.7M |
| 3 |
Tesla
TSLA
|
+$20.2M |
| 4 |
Apple
AAPL
|
+$14.6M |
| 5 |
ConocoPhillips
COP
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.63% |
| 2 | Healthcare | 13.36% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Financials | 12.67% |
| 5 | Communication Services | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
RenaissanceRe
RNR
$13.7B
| $3.81M | 0.04% |
22,969
-2,300
| -9% | -$391K |
|
452
Bio-Rad Laboratories Class A
BIO
$10.1B
| $3.79M | 0.04% |
6,500
-1,500
| -19% | -$854K |
|
453
Domino's
DPZ
$10.3B
| $3.77M | 0.04% |
9,825
+2,900
| +42% | +$1.14M |
|
454
Coca-Cola Europacific Partners
CCEP
$45.4B
| $3.76M | 0.04% |
75,450
-13,381
| -15% | -$565K |
|
455
Universal Health Services
UHS
$10.4B
| $3.74M | 0.04% |
27,203
-2,500
| -8% | -$311K |
|
456
ON Semiconductor
ON
$28.5B
| $3.73M | 0.04% |
113,903
+23,600
| +26% | +$658K |
|
457
International Flavors & Fragrances
IFF
$21.5B
| $3.73M | 0.04% |
34,240
+8,100
| +31% | +$909K |
|
458
Huntington Bancshares
HBAN
$33.8B
| $3.71M | 0.04% |
293,686
+53,500
| +22% | +$608K |
|
459
Wabtec
WAB
$47B
| $3.7M | 0.04% |
50,529
-9,100
| -15% | -$622K |
|
460
Lear
LEA
$6.22B
| $3.66M | 0.03% |
23,001
+5,800
| +34% | +$816K |
|
461
News Corp Class A
NWSA
$16.3B
| $3.61M | 0.03% |
200,976
+19,200
| +11% | +$310K |
|
462
XPO
XPO
$20.9B
| $3.61M | 0.03% |
87,627
| – | – |
|
463
Dentsply Sirona
XRAY
$1.96B
| $3.56M | 0.03% |
68,093
-1,000
| -1% | -$49.3K |
|
464
Howmet Aerospace
HWM
$89.6B
| $3.54M | 0.03% |
123,913
+65,800
| +113% | +$1.46M |
|
465
Jack Henry & Associates
JKHY
$10.8B
| $3.53M | 0.03% |
21,814
-3,700
| -15% | -$588K |
|
|
OPTU
466
Optimum Communications Inc
OPTU
$377M
| $3.53M | 0.03% |
93,148
-32,200
| -26% | -$1.01M |
|
|
KSU
467
DELISTED
Kansas City Southern
KSU
| $3.52M | 0.03% |
17,224
+1,400
| +9% | +$263K |
|
468
Whirlpool
WHR
$2.15B
| $3.51M | 0.03% |
19,440
+7,000
| +56% | +$1.34M |
|
469
10x Genomics
TXG
$9.69B
| $3.48M | 0.03% |
+24,600
| New | +$3.57M |
|
470
Hormel Foods
HRL
$11.4B
| $3.47M | 0.03% |
74,539
+24,600
| +49% | +$1.2M |
|
471
HEICO Corp Class A
HEI.A
$31.1B
| $3.46M | 0.03% |
29,600
+8,800
| +42% | +$958K |
|
472
Henry Schein
HSIC
$9.75B
| $3.44M | 0.03% |
51,498
+1,800
| +4% | +$116K |
|
473
Tyson Foods
TSN
$18.5B
| $3.43M | 0.03% |
53,193
+2,600
| +5% | +$162K |
|
474
Reinsurance Group of America
RGA
$16.2B
| $3.41M | 0.03% |
29,423
-6,000
| -17% | -$670K |
|
475
Western Union
WU
$2.14B
| $3.4M | 0.03% |
154,893
-53,300
| -26% | -$1.16M |
|
Similar funds
HNB
COPPSERS
HIIFS
RAM
AA
IG
LCIP
Fjarde Ap-fonden's Q4 2020 Portfolio in Review
As of Q4 2020, Fjarde Ap-fonden held 618 positions worth $10.5B, up 15% from $9.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Fjarde Ap-fonden's Q4 2020 filing shows 18 new, 256 increased, 279 reduced and 53 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 79,100 shares worth $5.79M. The largest sale was Chevron, an estimated $40.3M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fjarde Ap-fonden's largest Q4 2020 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 79,100 shares worth $5.79M.
- Fjarde Ap-fonden added most to iShares Core MSCI Emerging Markets ETF in Q4 2020, an estimated $169M increase.
- Fjarde Ap-fonden's biggest Q4 2020 reduction was Tesla, cutting an estimated $20.2M.
- Fjarde Ap-fonden fully exited Chevron in Q4 2020, selling an estimated $40.3M.
- Fjarde Ap-fonden's ten largest holdings make up 29% of its $10.5B portfolio in Q4 2020.
- Fjarde Ap-fonden opened 18 new positions and closed 53 in Q4 2020.
- Fjarde Ap-fonden's portfolio value rose 15% quarter-over-quarter to $10.5B.
Based on Fjarde Ap-fonden's 13F filing for Q4 2020, filed 12 Feb 2021.